- Low bankruptcy risk (Altman Z-Score: 11.40)
- Consistently positive technical signals over the last month
- Highly efficient cash conversion (97% FCF/OCF ratio)
Green day on Friday for Genmab A/S stock after gaining 0.80%
(Updated on Jul 31, 2026)
The Genmab A/S stock price gained 0.80% on the last trading day (Friday, 31st Jul 2026), rising from $28.64 to $28.87. During the last trading day the stock fluctuated 2.46% from a day low at $28.23 to a day high of $28.93. The price has risen in 6 of the last 10 days and is up by 0.52% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 421 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $60.05 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.97% during the next 3 months and, with a 90% probability hold a price between $28.72 and $33.93 at the end of this 3-month period.
GMAB Signals & Forecast
The Genmab A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $28.84 and $27.61. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, July 20, 2026, and so far it has risen 3.44%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Genmab A/S stock
Genmab A/S finds support from accumulated volume at $28.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.695 between high and low, or 2.46%. For the last week the stock has had daily average volatility of 2.04%.
Our recommended stop-loss: $27.36 (-5.22%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 9 days ago.)
Trading Expectations (GMAB) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect Genmab A/S to open at $28.68, and during the day (based on 14 day Average True Range), to move between $28.49 and $29.25, which gives a possible trading interval of +/-$0.755 (+/-2.65%) up or down from last closing price. If Genmab A/S takes out the full calculated possible swing range there will be an estimated 2.65% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $28.80 (0.24%) than the resistance at $29.00 (0.45%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Genmab A/S will release earnings BMO on Thursday, August 06, 2026.The consensus among the analysts for the expected earnings (EPS) is $0.370. We will update the financials statements for Genmab A/S, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.34% in the first trading day after earnings release.
Is Genmab A/S stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Genmab A/S stock to perform well in the short-term.
Current score:
1.844
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 3, 2026 - $28.68 ( 0.675%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
GMAB Performance
Trading levels for GMAB
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 29.37 | 1.73% |
| R2 | 29.10 | 0.81% |
| R1 | 28.94 | 0.244% |
| Price | 28.87 | |
| S1 | 28.41 | -1.60% |
| S2 | 28.25 | -2.16% |
| S3 | 27.98 | -3.08% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 29.78 | 3.15% |
| R2 | 29.54 | 2.32% |
| R1 | 29.00 | 0.450% |
| Price | 28.87 | |
| S1 | 28.80 | -0.242% |
| S2 | 27.21 | -5.75% |
| S3 | 26.43 | -8.45% |
FAQ
Click here for our free guide on how to buy Genmab A/S Stock.
Buy GMAB